| |
|
|
|
Xtalks, Online
2025-03-25
Increasing technological advances have the ability to impact many facets of drug development. Digital health technologies (DHTs) continue to improve the ability to reach more diverse patients, capture data continuously and passively outside traditional trial sites, and help create a more comprehensive understanding of patients’ lived experiences. Therefore, it is critical to understand how to select the most fit-for-purpose technology to de-risk trial operations and regulatory approval.
Grounded in a measures-first approach, which puts the most meaningful aspects of health at the forefront of protocol development, this webinar will cover how to identify, select and implement DHTs using evidence-backed insights. The expert speakers will review recent regulatory guidance for the use of DHTs in clinical research and expand on existing frameworks and industry standards that allow for confident decision-making in selecting fit-for-purpose technologies.
Register for this webinar today to explore how digital health technologies are transforming clinical trials by enabling continuous, passive data collection and enhancing patient engagement.
Keywords: Drug Development, Clinical Research, CRO, Patient Recruitment, Digital Health, Digital Health Technology, Digital Transformation, Digital Technologies, Digital Healthcare, Data Science
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Caprice Sassano, MPH, Senior Outcomes Researcher, ICON
Keith Thomas, Senior Director, Patient Centred Sciences, ICON
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2025-03-25
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|